Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines

Significant advances have been made recently in the development of targeted therapy for lung adenocarcinoma. However, platinum-based chemotherapy remains as the cornerstone in the treatment of this neoplasm. This is the treatment option for adenocarcinomas without EGFR gain-of-function mutations or...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavez-Dominguez, Rodolfo L., Perez-Medina, Mario A., Lopez-Gonzalez, Jose S., Galicia-Velasco, Miriam, Matias-Florentino, Margarita, Avila-Rios, Santiago, Rumbo-Nava, Uriel, Salgado-Aguayo, Alfonso, Gonzalez-Gonzalez, Claudia, Aguilar-Cazares, Dolores
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710495/
https://www.ncbi.nlm.nih.gov/pubmed/34966671
http://dx.doi.org/10.3389/fonc.2021.750677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710495/
https://www.ncbi.nlm.nih.gov/pubmed/34966671
http://dx.doi.org/10.3389/fonc.2021.750677

Ejemplares similares